- Home
- ONC vs CBOE Comparison
ONC vs CBOE Comparison
Compare ONC & CBOE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONC
- CBOE
- Stock Information
- Founded
- ONC 2010
- CBOE 1973
- Country
- ONC Switzerland
- CBOE United States
- Employees
- ONC N/A
- CBOE N/A
- Industry
- ONC Biotechnology: Pharmaceutical Preparations
- CBOE Investment Bankers/Brokers/Service
- Sector
- ONC Health Care
- CBOE Finance
- Exchange
- ONC Nasdaq
- CBOE Nasdaq
- Market Cap
- ONC 26.9B
- CBOE 23.7B
- IPO Year
- ONC N/A
- CBOE 2010
- Fundamental
- Price
- ONC $250.30
- CBOE $235.29
- Analyst Decision
- ONC Strong Buy
- CBOE Hold
- Analyst Count
- ONC 9
- CBOE 14
- Target Price
- ONC $325.56
- CBOE $224.71
- AVG Volume (30 Days)
- ONC 345.1K
- CBOE 624.2K
- Earning Date
- ONC 08-06-2025
- CBOE 08-01-2025
- Dividend Yield
- ONC N/A
- CBOE 1.07%
- EPS Growth
- ONC N/A
- CBOE 2.12
- EPS
- ONC N/A
- CBOE 7.62
- Revenue
- ONC $4,175,868,000.00
- CBOE $4,332,300,000.00
- Revenue This Year
- ONC $869.15
- CBOE N/A
- Revenue Next Year
- ONC $19.07
- CBOE $4.18
- P/E Ratio
- ONC N/A
- CBOE $30.90
- Revenue Growth
- ONC 51.16
- CBOE 15.76
- 52 Week Low
- ONC $146.21
- CBOE $168.16
- 52 Week High
- ONC $287.88
- CBOE $237.27
- Technical
- Relative Strength Index (RSI)
- ONC N/A
- CBOE 60.85
- Support Level
- ONC N/A
- CBOE $230.26
- Resistance Level
- ONC N/A
- CBOE $237.27
- Average True Range (ATR)
- ONC 0.00
- CBOE 4.82
- MACD
- ONC 0.00
- CBOE 0.40
- Stochastic Oscillator
- ONC 0.00
- CBOE 85.58
About ONC BeiGene Ltd. American Depositary Shares
Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeiGene is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeiGene runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeiGene's revenue.
About CBOE Cboe Global Markets Inc.
Cboe Global Markets Inc is a provider of market infrastructure and tradable products, that delivers cutting-edge trading, clearing, and investment solutions to market participants around the world. The Company is committed to operating a trusted, inclusive all over world marketplace, and to providing products, technology, and data solutions that enable participants to define a sustainable financial future. Cboe provides trading solutions and products in multiple asset classes, including equities, derivatives, FX, and digital assets, across North America, Europe, and Asia Pacific.